Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | |
| Operating Expenses | 1,048 | 1,444 | 0 |
| Operating Income | -1,048 | -1,444 | N/A |
| Other Income | 177 | 99 | 0 |
| Pre-tax Income | -871 | -1,345 | 0 |
| Net Income Continuous | -871 | -1,345 | -983 |
| Net Income | $-871 | $-1,345 | $-983 |
| EPS Basic Total Ops | -0.02 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.02 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.04 | -0.03 |
| EBITDA(a) | $-1,045 | $-1,441 | $N/A |